1[1]Bloss JD, Liao SY, Buller RE, et al. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol,1993, 50: 347-351.
2[2]Gompel C, Silverberg SG. The female peritoneum. In Gompel C, Silverberg SG (eds): Pathology in Gynecology and Obstetrics. Philadelphia: JB Lippincott, 1994.414.
3[3]Weir MM, Bell DA, Young RH. Grade 1 peritoneal serous carcinoma: a report of 14 cases and comparison with 7 peritoneal serous psammocarcinomas and 19 peritoneal serous borderline tumors. Am J Surg Pathol, 1998,22: 849.
4[4]Fromm GL, Gershenson DM, Silva EG, et al. Papillary serous carcinoma of the peritoneum.Obstet Gynecol,1990, 75:89-95.
5[5]Eltabbakh GH, Piver S, Natarajan N, et al. Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer. Obstet Gynecol, 1998,91:254-259.
6[6]Bloss JD, Brady MF, Liao SY, et al. Extraovarian peritoneal serous papillary carcinoma:a phase Ⅱ trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study. Gynecologic Oncology, 2003, 89:148-154.
7[7]Eltabbakh GH, Werness BA, Piver MS, et al. Prognostic factors in extra-ovarian primary peritoneal carcinoma. Gynecol Oncol, 1998, 71: 230-239.
8[8]Piver MS, Eltabbakh GH, Hempling RE, et al. Two sequential studies for primary peritoneal carcimoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophoaphamide or paclitaxel-cisplatin. Gynecol Oncol,1997,67:141-146.
10[10]Ransom DT,Patel SR,Keeney GL, et al. Papillary serous carcinoma of the peritoneum:a review of 33 cases treated with platin-based chemotherapy. Cancer, 1990,(66)sep:1091-1094.
二级参考文献16
1Fromm GL, Gershenson DM, Silva EG. Papillary serous carcinoma of the peritoneum. Obstet Gynecol, 1990,75:89-95.
2Bloss JD, Liao SY, Buller RE, et al. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol,1993,50:347-351.
3Swerdlow M. Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary; case report.Am J Obstet Gynecol,1959,77:197-200.
4Eltabbakh GH, Piver MS, Natarajan N, et al. Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer. Obstet Gynecol,1998,91:254-259.
5Bloss JD, Brady MF, Liao SY, et al. Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study. Gynecol Oncol,2003,89:148-154.
6Piver MS, Jishi MF, Tsukada Y, et al. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry. Cancer,1993,71: 2751-2755.
7Piver MS, Eltabbakh GH, Hempling RE, et al. Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin. Gynecol Oncol, 1997,67:141-146.
8Altaras MM, Aviram R, Cohen I, et al. Primary peritoneal papillary serous adenocarcinoma: clinical and management aspects. Gynecol Oncol,1991,40:230-236.
9Muto MG, Welch WR, Mok SC, et al. Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res,1995, 55:490-492.
10Eltabbakh GH, Werness BA, Piver S, et al. Prognostic factors in extraovarian primary peritoneal carcinoma. Gynecol Oncol, 1998,71:230-239.
5Chu CS,Menzin AW,Leonare DGB,et al.Primary peritoneal carcinoma:a review of the literature obsterical & gynecological[J].Survey(LWW),1999,54(5):323-335.
